Results 21 to 30 of about 3,167,167 (225)

Alcohol abuse as a risk factor for developing thyroid cancer [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2021
Introduction/Objective. Alcohol abuse influence on developing thyroid cancer is controversial. While some studies consider it a protective factor, others deny any impact on thyroid cancer.
Kalezić Nevena, Karadžić-Kočica Milica, Dimić Nemanja, Kočica Mladen, Tošković Anka, Jovanović Milan, Dimitrijević Ivan   +6 more
doaj   +1 more source

Tumour-to-tumour metastasis: Rectal adenocarcinoma metastasis to medullary carcinoma of thyroid—Case report and review of the literature

Human Pathology Reports, 2022
Tumour-to-tumour metastasis is a rare incidence. Metastasis from colorectal cancer to primary thyroid neoplasm is extremely rare. We report a case of metastatic rectal adenocarcinoma to a medullary thyroid carcinoma.
Mahmoud Elsayed, Andrew McCarthy, Marium Khan   +2 more
doaj   +1 more source

A rare presentation of medullary thyroid cancer metastasis to the prostate in a patient with multiple endocrine neoplasia 2B syndrome treated with laparoscopic radical prostatectomy

Urology Annals, 2023
Multiple endocrine neoplasia (MEN) syndromes are rare and potentially malignant hereditary entities. Clinical manifestations of MEN 2B include medullary thyroid cancer, pheochromocytoma, gastrointestinal ganglioneuromatosis, and musculoskeletal and ...
Theodoros Spinos, Dimitrios Ermidis, Christos Zabaftis, Filippos Nikitakis, Nikolaos Grivas, Markos Karavitakis   +5 more
doaj   +1 more source

Principles of medullary thyroid cancer staging according to AJCC TNM 8th edition

Acta Medica Leopoliensia, 2021
Aim. The research aims at analyzing the main changes in classification of medullary thyroid cancer and outlining the principles of staging according to modern studies. Material and Methods.
O.R Duda, R.R. Slipetsky, N.I. Bojko
doaj   +1 more source

Medullary thyroid cancer in combination with autoimmune thyroiditis after COVID-19

Сибирский онкологический журнал, 2022
Background. Coronavirus disease 2019 (COVID-19) is a pandemic of the new millennium. COVID-19 can cause both pulmonary and systemic infammation, and can rapidly progress to multiple organ failure. Data on the relationship between COVID-19 and the thyroid
E. V. Ryabchenko
doaj   +1 more source

Successful Treatment with Selpercatinib for Ectopic Cushing’s Syndrome Due to Medullary Thyroid Cancer

Current Oncology, 2022
Selpercatinib, a RET kinase inhibitor, is an effective treatment for patients with medullary thyroid cancer with RET mutations. In this paper, we present the case of a 62-year-old man with ectopic Cushing’s syndrome due to medullary thyroid cancer who ...
Oskar Ragnarsson, Marta Piasecka, Andreas Hallqvist   +2 more
doaj   +1 more source

Diagnosis of medullary thyroid cancer [PDF]

F1000 Medicine Reports, 2009
Medullary thyroid cancer (MTC) accounts for 5-10% of all thyroid cancers. The majority of medullary thyroid cancers are sporadic, but 25% of cases are inherited as a result of germline mutations in the RET proto-oncogene. In sporadic cases MTC presents as a thyroid nodule discovered at palpation or at thyroid ultrasonography, and is indistinguishable ...
Marchisotta, Stefania, Pacini, Furio
openaire   +2 more sources

Emerging role of multikinase inhibitors for refractory thyroid cancer

Biologics: Targets & Therapy, 2012
Cesar A Perez,1 Belisario A Arango,1 Michel Velez,1 Luis E Raez,2 Edgardo S Santos11University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center, Miami, USA; 2Memorial Cancer Institute, Memorial Health Care System, Hollywood, FL ...
Perez CA, Arango BA, Velez M, Raez LE, Santos ES   +4 more
doaj   +1 more source

Case Report: Medullary Thyroid Cancer Workup Initiated by Unexpectedly High Procalcitonin Level—Endocrine Training Saves Life in the COVID-19 Unit

Frontiers in Endocrinology, 2021
BackgroundSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that has caused a worldwide pandemic. The majority of medullary thyroid cancers present as a thyroid nodule.
Livia Sira, Zoltán Balogh, Eszter Vitális, Dávid Kovács, Ferenc Győry, Csaba Molnár, Miklos Bodor, Endre V. Nagy   +7 more
doaj   +1 more source

Cabozantinib in Progressive Medullary Thyroid Cancer [PDF]

Journal of Clinical Oncology, 2013
Purpose Cabozantinib, a tyrosine kinase inhibitor (TKI) of hepatocyte growth factor receptor (MET), vascular endothelial growth factor receptor 2, and rearranged during transfection (RET), demonstrated clinical activity in patients with medullary thyroid cancer (MTC) in phase I.
ELISEI, ROSSELLA, Schlumberger, Martin J., Müller, Stefan P., Schöffski, Patrick, Brose, Marcia S., Shah, Manisha H., Licitra, Lisa, Jarzab, Barbara, Medvedev, Viktor, Kreissl, Michael C., Niederle, Bruno, Cohen, Ezra E. W, Wirth, Lori J., Ali, Haythem, Hessel, Colin, Yaron, Yifah, Ball, Douglas, Nelkin, Barry, Sherman, Steven I.   +18 more
openaire   +6 more sources